StreetInsider.com  Oct 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Compugen+%28CGEN%29+Says+It+Acheived+Second+Preclinical+Milestone+in+Collaboration+with+Bayer/9909318.html for the full story.
StreetInsider.com  Oct 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Compugen+Ltd+%28CGEN%29+Discloses+Results+from+Additional+CGEN-15049+Studies/9874315.html for the full story.
SeekingAlpha  Sep 30  Comment 
By Lior Ronen: In an earlier article published this year, I raised a concern of an Israeli IPO tech bubble evolving in the US stock markets. In this article, I would like to revisit that theory, check the status of the previously discussed...
StreetInsider.com  Aug 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Compugen+Ltd+%28CGEN%29+Appoints+New+CFO/9778748.html for the full story.
StreetInsider.com  Aug 21  Comment 
* Family Dollar Stores (NYSE: FDO) announced that its Board of Directors has unanimously rejected the non-binding proposal made by Dollar General Corporation (NYSE: DG) on the basis of antitrust regulatory considerations. In addition, the Family...
StreetInsider.com  Aug 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Compugen+Ltd+%28CGEN%29+Reacquires+Certain+Rights+to+Pipeline+Program+Candidates+from+Baize/9772932.html for the full story.
SeekingAlpha  Aug 6  Comment 
Compugen Ltd.(NASDAQ:CGEN) Q2 2014 Earnings Conference Call August 6, 2014 10:00 AM ET Executives Martin S. Gerstl – Chairman of the Board of Directors Anat Cohen-Dayag – President & Cheif Executive Officer Avihai Shen –...
MarketWatch  Jul 7  Comment 
Compugen Ltd. shares rose almost 4% in premarket trade Monday, after the company said it has achieved an initial milestone in a cancer immunotherapy partnership with Bayer Healthcare, a unit of Bayer AG . The company said the milestone relates to...
Benzinga  Jun 18  Comment 
Analysts at JMP Securities initiated coverage on shares of Compugen (NASDAQ: CGEN) with a “market outperform” rating. The target price for Compugen is set to $14. Compugen's shares closed at $9.06 yesterday. Wedbush initiated coverage on...
Motley Fool  Jun 16  Comment 
Compugen shares ascend to the heavens after disclosing initial data on one of its experimental immune checkpoint candidates. Find out whether or not this pop is deserved.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki